|
||||||||||||||||||
|
|
||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe KMI6 monoclonal antibody reacts with mouse CD29 (integrin β1), a 120-130 kDa member of the β integrin family expressed by leukocytes, endothelial, smooth muscle and epithelial cells. CD29 binds non-covalently with the α integrins CD49a-f, to form the VLA-1 through VLA-6 complexes, respectively, and also with CD51. These αβ integrin heterodimers are capable of mediating a variety of cellular responses including adhesion, trafficking, proliferaton and differentiation. All of the integrins which include CD29 bind to extracellular matrix proteins including collagen, laminin, fibronectin and vitronectin, whereas some CD29-containing integrins also interact with cellular receptors including VCAM-1 and MadCAM-1. The KMI6 antibody has been shown to be an activating antibody for β1 integrins, enhancing lymphocyte binding to fibronectin. Applications ReportedFor research use only, not for diagnostic or therapeutic use. This KMI6 antibody has been reported for use in flow cytometric analysis, immunoprecipitation, and immunohistology staining of frozen tissue sections. The KMI6 antibody has also been found useful for immunoblotting, recognizing a protein of approximately 120 kD under non-reducing conditions. Applications TestedThis KMI6 antibody has been tested by flow cytometric analysis of mouse splenocytes and thymocytes. This can be used at less than or equal to 0.125 μg per million cells in a 100 μl total staining volume. The KMI6 antibody has also been tested by immunoblotting at 2 μg/ml. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. References
Aoyama K, Oritani K, Yokota T, Ishikawa J, Nishiura T, Miyake K, Kanakura Y, Tomiyama Y, Kincade PW, Matsuzawa Y. Stromal cell CD9 regulates differentiation of hematopoietic stem/progenitor cells. Blood. 1999 Apr 15;93(8):2586-94. (KMI6, IP, WB, PubMed) Wadsworth SA, Chang AC, Hong MJ, Halvorson MJ, Otto S, Coligan JE. Expression of a novel integrin β1 chain epitope and anti-β1 antibody-mediated enhancement of fibronectin binding are dependent on the stage of T cell differentiation. J Immunol. 1995 Mar 1;154(5):2125-33. (KMI6, FC, IP, FA, PubMed) Jacobsen K, Miyake K, Kincade PW, Osmond DG. Highly restricted expression of a stromal cell determinant in mouse bone marrow in vivo. J Exp Med. 1992 Oct 1;176(4):927-35. (KMI6, IP, PubMed) Related ProductsCat. 14-0291 Affinity Purified anti-mouse CD29 (Integrin b1 chain, a4b1, VLA-4) (clone eBioHMb1-1 (HMb1-1)) Cat. 14-0297 Purified anti-human CD29 (Integrin beta 1) (clone MEM-101A) Cat. 11-4317 Streptavidin-FITC (Fluorescein isothiocyanate) Cat. 12-4317 Streptavidin-PE (Phycoerythrin) Cat. 17-4317 Streptavidin Allophycocyanin (SA-APC) Cat. 14-4321 Affinity Purified Rat IgG2a Isotype Control Cat. 11-4811 FITC Anti-Rat IgG Cat. 13-4813 Biotin Anti-Rat IgG (clone Polyclonal) |
|||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |